A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24341
Abstract: Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is difficult due to the lack of effective screening tests. CA199, the standard biomarker for PDAC management, is not sufficiently reliable for early diagnosis. This prospective study aimed… read more here.
Keywords: circulating tumor; diagnosis pancreatic; diagnosis; tumor cells ... See more keywords